tm logo

Monitor this mark

View On USPTO

MEZAVANT
Live/Registered
REGISTERED

on 23 Apr 2024

Last Applicant/ Owned by

Nogra Pharma Limited

33 Sir John Rogerson's Quay

Dublin

IE

2

Serial Number

97917543 filed on 02th May 2023

Registration Number

7366986 registered on 23rd Apr 2024

in the Principal Register

Correspondent Address

Rebecca Liebowitz

Rebecca Liebowitz VENABLE LLP

WASHINGTON, DC 20043

UNITED STATES

Filing Basis

No Filing Basis

Disclaimer

NO DATA

MEZAVANT

Pharmaceutical preparations, namely, aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97917543

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 132115578945

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
23rd Apr 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
23rd Apr 2024REGISTERED-PRINCIPAL REGISTER
06th Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06th Feb 2024PUBLISHED FOR OPPOSITION
17th Jan 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30th Dec 2023APPROVED FOR PUB - PRINCIPAL REGISTER
30th Dec 2023ASSIGNED TO EXAMINER
14th Dec 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
14th Dec 2023ASSIGNED TO LIE
17th Jul 2023TEAS VOLUNTARY AMENDMENT RECEIVED